FIFTH COMMUNITY PHARMACY AGREEMENT CONSULTATIONCommunity Pharmacy Agreement • November 4th, 2014
Contract Type FiledNovember 4th, 20145CPA component Consultation activity With whom Timeframe Action taken in response 5CPA programmes • Consumer views on the services and advice provided by pharmacies to consumers;• The location of pharmacies;• Issues relevant to competition between pharmacies; and• Increased accountability of pharmacy owners for the professional pharmacy services provided to consumers. • CHF December 2009 –December 2010 • Advice provided informed policy options and negotiations for 5CPA. Medication Use Reviews (MedsCheck) and Diabetes Medication Management Service (Diabetes MedsCheck) Advice sought on patient eligibility for the MedsCheck and Diabetes MedsCheck pilots • PRG December 2010 –June 2012 • Inclusion of ‘improved adherence’ to the aims of the programme.• Use of broad patient eligibility criteria initially for the pilot that could be refined to inform the national roll-out.• Added ‘significant medical event and complexity/type of administration’ as an additional indicator to number of drugs inc
SIXTHCommunity Pharmacy Agreement • May 25th, 2015
Contract Type FiledMay 25th, 2015The 6CPA General Terms and Conditions are currently available in draft form and will shortly be updated to comply with the Commonwealth Grants Rules and Guidelines. Updates to these terms and conditions will not change the intent of the programmes, but will provide additional clarity for participants. The programmes will continue to operate under these draft terms and conditions until updated terms and conditions are published.
THE FIFTH COMMUNITY PHARMACY AGREEMENTCommunity Pharmacy Agreement • August 5th, 2010
Contract Type FiledAugust 5th, 2010
DEEDCommunity Pharmacy Agreement • August 29th, 2023 • Australian Capital Territory
Contract Type FiledAugust 29th, 2023 Jurisdiction
Specification for Supervised ConsumptionCommunity Pharmacy Agreement • March 24th, 2016
Contract Type FiledMarch 24th, 2016This document sets out a service specification for a community pharmacy ‘supervised consumption’ service to be provided by the contractor to service users who are prescribed methadone or buprenorphine and will encompass supervised support and advice to service users in a safe environment. The practice is designed to support service users to stop or stabilise their opiate use thus enabling them to develop their personal goals.